Title for MeetingAbstracts
Alphabetical listing of titles
Preclinical Evaluation of Gene-Delivery-Based HIV-1 Vaccines in Nonhuman Primates.
Preclinical evaluation of immunogenicity and toxicity of a polyvalent DNA prime and envelope protein boost HIV-1 vaccine.
PRECLINICAL EVALUATION OF INDIAN HIV-1 SUBTYPE C VACCINE CONSTRUCTS IN MICE AND MONKEYS.
Preclinical immunogenicity of a multiprotein DNA/MVA vaccine for HIV-1.
Preclinical Immunogenicity Studies on Pilot Lots of a Prototype VEE Replicon Vector HIV-1 Subtype C Vaccine for South Africa.
Preclinical immunogenicity studies with Thai E rgp120/MF59 vaccine.
Preclinical Investigations into the Mechanism by Which HIV Protease Inhibitors May Induce Metabolic Disorders.
Preclinical pharmacokinetic evaluation in rat brain and plasma of selected urea-PETT compounds. Eleventh International Conference on Antiviral Research.
Preclinical Pharmacokinetic Profile of ABT-773 in Mouse, Rat, Monkey, and Dog.
Preclinical Pharmacokinetics of a Series of Nonfluoroquinolones (NFQs).
Preclinical pharmacology of an anti-HIV oligonucleotide (AR177).
Preclinical safety evaluation of DNA and recombinant fowlpox prime/boost vaccines expressing multiple HIV proteins from subtype B and A/E strains.
Preclinical safety evaluation of emtricitabine (coviracil).
Preclinical Studies on a Group Y Meningococcal Conjugate Vaccine.
Preclinical Studies on the Development of an Optimal Meningococcal CYW Conjugate Vaccine.
Preclinical Testing of an HIV-1 Envelope-containing Heat-treated Pseudovirion Vaccine.
Preclinical testing of the anti-HIV activity of FddA in hu-PBL SCID mice.
Preclinical toxicokinetic studies with AG1343, an orally bioavailable HIV-1 protease inhibitor.
Precondition for HTA in management education in Slovak Republic.
Predicators of longitudinal nonadherence among clients enrolled in the treatment adherence demonstration project.
Predictability of HIV status in Haitian adults.
Predictability of sustained virological response (SVR) in patients with HCV/HIV co-infection during combination therapy with peginterferon alfa-2A (40KD) (Pegasys) plus ribavirin (Copegus) in the APRICOT trial.
Predictability of vertical HIV-1 transmission based on mitogen-induced p24 in cultures of maternal peripheral blood mononuclear cells.
Predicted impact on hospital workloads from large scale HAART provision in Thailand in 2004-2010.
Predicted incidence and cost of Pneumocystis carinii pneumonia in a state prison population with and without prophylaxis.
Predicting 10-year outcomes of Alzheimer's disease.
Predicting acceptance and use of condoms in adolescence in West and East Berlin.
Predicting acceptance of highly active antiretroviral treatment (HAART): the role of patients' perceptions of illness and treatment.
Predicting Access to Medical Care Among Out of Treatment Drug Users.
Predicting adherence: doctor relations and gay scene involvement.